Table 4.
Distribution of Community Pharmacists’ Practices Toward Medication History-Taking, and Identification of the Presence of DDIs After Simulated Patients (SP) Provided Patient’s Medication History in Both Scenarios
| Practice | Number (%) of Pharmacists | |
|---|---|---|
| Scenario 1 | Scenario 2 | |
| Asking about medication history | ||
| Yes | 0 (0) | 0 (0) |
| No | 235 (100) | 235 (100) |
| Identification of the presence of DDIs after SP provided patient’s medication history | ||
| Yes | 32 (13.6) | 55 (23.4) |
| No | 203 (86.4) | 180 (76.6) |
| The identification of DDIs by community pharmacists in scenario 1 (patient taking simvastatin) (n= 32) | ||
| Simvastatin with clarithromycin | 6 (18.8) | |
| Simvastatin with itraconazole | 7 (21.9) | |
| Simvastatin interaction with both drugs | 19 (59.4) | |
| The identification of DDIs by community pharmacists in scenario 2 (patient taking warfarin) (n= 55) | ||
| Warfarin with cotrimoxazole | 2 (3.6) | |
| Warfarin with metronidazole | 12 (21.8) | |
| Warfarin interaction with both drugs | 41 (74.5) | |